- Home
- HUHU vs ADAG Comparison
HUHU vs ADAG Comparison
Compare HUHU & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUHU
- ADAG
- Stock Information
- Founded
- HUHU 2015
- ADAG 2011
- Country
- HUHU China
- ADAG China
- Employees
- HUHU N/A
- ADAG N/A
- Industry
- HUHU
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- HUHU
- ADAG Health Care
- Exchange
- HUHU NYSE
- ADAG Nasdaq
- Market Cap
- HUHU 86.8M
- ADAG 85.9M
- IPO Year
- HUHU 2024
- ADAG 2021
- Fundamental
- Price
- HUHU $4.56
- ADAG $1.80
- Analyst Decision
- HUHU
- ADAG Strong Buy
- Analyst Count
- HUHU 0
- ADAG 1
- Target Price
- HUHU N/A
- ADAG $5.00
- AVG Volume (30 Days)
- HUHU 57.2K
- ADAG 23.1K
- Earning Date
- HUHU 02-22-2025
- ADAG 03-09-2025
- Dividend Yield
- HUHU N/A
- ADAG N/A
- EPS Growth
- HUHU 13.14
- ADAG N/A
- EPS
- HUHU 0.08
- ADAG N/A
- Revenue
- HUHU $17,492,735.00
- ADAG $815,746.00
- Revenue This Year
- HUHU N/A
- ADAG N/A
- Revenue Next Year
- HUHU N/A
- ADAG $2.70
- P/E Ratio
- HUHU $55.65
- ADAG N/A
- Revenue Growth
- HUHU 33.03
- ADAG N/A
- 52 Week Low
- HUHU $3.52
- ADAG $1.74
- 52 Week High
- HUHU $9.89
- ADAG $4.38
- Technical
- Relative Strength Index (RSI)
- HUHU N/A
- ADAG 39.32
- Support Level
- HUHU N/A
- ADAG $1.76
- Resistance Level
- HUHU N/A
- ADAG $1.89
- Average True Range (ATR)
- HUHU 0.00
- ADAG 0.13
- MACD
- HUHU 0.00
- ADAG -0.00
- Stochastic Oscillator
- HUHU 0.00
- ADAG 11.76
About HUHU HUHUTECH INTL GROUP INC
HUHUTECH International Group Inc specializes in providing factory facility management and monitoring systems, including high-purity gas, chemicals and liquid system and factory management and control systems for industrial clients, who are mainly semi-conductor manufacturers and electronics manufacturers in China. The products and services are widely used by semi-conductor manufacturers, LED and micro-electronics factories, as well as some pharmaceutical, food and beverage manufacturers.
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.